1. Home
  2. HLN

as 12-03-2024 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Consumer Discretionary

Package Goods/Cosmetics

Nasdaq

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Founded: 2022 Country:
United Kingdom
United Kingdom
Employees: N/A City: N/A
Market Cap: 43.7B IPO Year: N/A
Target Price: $10.48 AVG Volume (30 days): 6.5M
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
1.62%
Dividend Payout Frequency: Semi-Annual
EPS: 0.18 EPS Growth: -2.93
52 Week Low/High: $7.89 - $10.80 Next Earning Date: 08-01-2024
Revenue: $15,065,004,686 Revenue Growth: -0.65%
Revenue Growth (this year): 2.92% Revenue Growth (next year): 2.80%

HLN Daily Stock ML Predictions

Share on Social Networks: